Catalyst Event
Medpace Holdings Inc (MEDP) · Earnings Release
From KEDI Global Longevity Bio Index (KGLB)
4/22/2026, 12:00:00 AM
Q1 2026 earnings results are scheduled to be released after market close on April 22, 2026, with a conference call the following morning. Market reaction is unknown, but earnings releases are typically significant events, scheduled.
Korean Translation
2026년 1분기 실적 발표가 2026년 4월 22일 장 마감 후로 예정됨. 다음 날 오전에 컨퍼런스 콜이 예정되어 있으며, 시장 반응은 아직 알 수 없으나 실적 발표는 일반적으로 중요한 이벤트이므로 변동성이 예상됨.
Related Recent Events
Novo Nordisk A/S (NVO) · Other
Announced on Feb 24, 2026, that it will lower the U.S. list prices of key drugs Wegovy and Ozempic by approximately 50% and 35% respectively, effective January 1, 2027, to improve patient access.
1/1/2027, 12:00:00 AM
Novartis AG (NVS) · Other
Results from the Phase III Lp(a)HORIZON study of cardiovascular candidate pelacarsen are scheduled for 2026-06-30; this key clinical readout is estimated to have a >5% price impact expected.
6/30/2026, 12:00:00 AM
RELX PLC (RELX) · Other
Ex-dividend date for the 48.0 pence per share final dividend for fiscal year 2025 on May 7, 2026; dividend-related price adjustments are typically low, scheduled
5/7/2026, 12:00:00 AM
Novo Nordisk A/S (NVO) · Earnings Release
First quarter 2026 earnings release is scheduled.
5/6/2026, 12:00:00 AM
Leidos Holdings Inc (LDOS) · Earnings Release
Leidos is scheduled to release Q1 2026 financial results on May 5, 2026, with analysts forecasting EPS of $2.91-$2.94 expected.
5/5/2026, 12:00:00 AM
Pfizer Inc (PFE) · Earnings Release
Pfizer's Q1 2026 earnings release is scheduled for May 5, 2026, scheduled.
5/5/2026, 12:00:00 AM